Multi Manager Access II - Future of Humans USD Q-acc

Reference Data

ISIN LU2204946912
Valor Number 55896852
Bloomberg Global ID MUFOHUQ LX
Fund Name Multi Manager Access II - Future of Humans USD Q-acc
Fund Provider UBS Switzerland AG, Zurich Basel, Switzerland
Phone: +41 61 288 75 01
E-Mail: sh-ubs-funds-feedback@ubs.com
Web: www.ubs.com/fonds
Fund Provider UBS Switzerland AG, Zurich
Representative in Switzerland UBS Fund Management (Switzerland) AG
Basel
Phone: +41 61 288 49 10
Distributor(s) UBS Fund Management (Switzerland) AG
Basel
Phone: +41 61 288 49 10
Asset Class Other Funds
EFC Category Equity Global
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** The investment objective of the actively managed sub-fund is to seek long-term real returns. No guarantee can be given that this investment objective will be achieved. The sub-fund is categorized as an ESG Integrated Fund. However, the sub-fund does not promote particular ESG characteristics or pursue a specific sustainability or impact objective. The investments underlying this financial product do not take into account the EU criteria for environmentally sustainable economic activities.
Peculiarities

Fund Prices

Current Price * 100.92 USD 31.10.2024
Previous Price * 101.66 USD 30.10.2024
52 Week High * 102.85 USD 30.09.2024
52 Week Low * 84.13 USD 02.11.2023
NAV * 100.92 USD 31.10.2024
Issue Price * 100.92 USD 31.10.2024
Redemption Price * 100.92 USD 31.10.2024
Closing Price *
Indicative Minimum Price
Fund Assets *** 55,849,582
Unit/Share Assets *** 17,360,263
Trading Information SIX

Performance

YTD Performance +7.44% 29.12.2023
31.10.2024
YTD Performance (in CHF) +10.28% 29.12.2023
31.10.2024
1 month -1.88% 30.09.2024
31.10.2024
3 months +2.53% 31.07.2024
31.10.2024
6 months +8.18% 30.04.2024
31.10.2024
1 year +22.45% 31.10.2023
31.10.2024
2 years +22.85% 31.10.2022
31.10.2024
3 years -14.63% 02.11.2021
31.10.2024
5 years +0.92% 19.10.2020
31.10.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

UnitedHealth Group Inc 2.53%
Novo Nordisk AS Class B 2.27%
Boston Scientific Corp 2.24%
Danaher Corp 2.17%
Amazon.com Inc 2.02%
Booking Holdings Inc 2.02%
Meta Platforms Inc Class A 1.97%
Netflix Inc 1.96%
Eli Lilly and Co 1.96%
Bristol-Myers Squibb Co 1.88%
Last data update 31.10.2024

Cost / Risk

TER 1.03%
TER date 31.07.2023
Performance Fee *** 0.00%
PTR
Max. Management Fee *** 0.77%
Ongoing Charges *** 1.00%
SRRI ***
SRRI date *** 30.09.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)